Mitigating Health and Science Misinformation: A Scoping Review of Literature from 2017 to 2022.
Kathryn HeleyWen-Ying Sylvia ChouHeather D'AngeloNicole Senft EversonAbigail MuroJacob A RohdeAnna GaysynskyPublished in: Health communication (2024)
Literature on how to address misinformation has rapidly expanded in recent years. The aim of this scoping review was to synthesize the growing published literature on health and science misinformation mitigation interventions. English-language articles published from January 2017 to July 2022 were included. After title/abstract screening, 115 publications (148 empirical studies) met inclusion criteria and were coded for sample characteristics, topics, mitigation strategies, research methods, outcomes, and intervention efficacy. A marked increase in misinformation mitigation research was observed in 2020-2022. COVID-19, vaccines, and climate change were the most frequently addressed topics. Most studies used general population samples recruited online; few focused on populations most vulnerable to misinformation. Most studies assessed cognitive outcomes (e.g., knowledge), with fewer assessing health behavior, communication behavior, or skills. Correction (k = 97) was the most used misinformation mitigation strategy, followed by education and other literacy initiatives (k = 39) and prebunking/inoculation (k = 24). Intervention efficacy varied, with 76 studies reporting positive, 17 reporting null, and 68 reporting mixed results. Most misinformation mitigation interventions were limited to short-term online experiments focused on improving cognitive outcomes. Priority research areas going forward include expanding and diversifying study samples, scaling interventions, conducting longitudinal observations, and focusing on communities susceptible to misinformation.
Keyphrases
- social media
- health information
- climate change
- healthcare
- public health
- systematic review
- human health
- randomized controlled trial
- case control
- mental health
- physical activity
- sars cov
- adverse drug
- coronavirus disease
- autism spectrum disorder
- quality improvement
- tyrosine kinase
- adipose tissue
- insulin resistance
- health promotion
- meta analyses
- respiratory syndrome coronavirus